RPR SONS ADVISORS PRIVATE LIMITED, P.SUNEELA RAN Jointly Holding's most recent trade in Aurobindo Pharma Ltd. was a Pledge of 3,016,000 Equity Shares done at an average price of Rs. 828.9 . Disclosure was reported to the exchange on Dec. 21, 2020 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
RPR SONS ADVISORS PRIVATE LIMITED, P.SUNEELA RAN Jointly Holding's has made SAST transactions in Aurobindo Pharma Ltd. recently where a Pledge of 2,860,000 shares done . Disclosure was reported to the exchange on July 10, 2020.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED P SUNEELA RANI Jointly holding | Promoter | Pledge | 24 Dec 2024 | 2,860,000 | 2,860,000 | - | - | 07 Jul 2020 07 Jul 2020 |
SAST (Reg31) | - | Creation | |
Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED, P.SUNEELA RAN Jointly Holding | Promoter | Pledge | 24 Dec 2024 | 9,000,000 | 21,576,000 | - | - | 01 Feb 2021 01 Feb 2021 |
SAST (Reg31) | - | Creation | |
Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED. P .SUNEELA RANI (Jointly holding) | Promoter | Pledge | 24 Dec 2024 | 220,000 | 27,516,000 | - | - | 24 Mar 2021 24 Mar 2021 |
SAST (Reg31) | - | Creation | |
Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED, P,SUNEELA RANI (Jointly holding | Promoter | Pledge | 24 Dec 2024 | 1,540,000 | 29,056,000 | - | - | 25 Mar 2021 25 Mar 2021 |
SAST (Reg31) | - | Creation | |
Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED. P.SUNEELA RANI Jointly holding | Promoter | Pledge | 24 Dec 2024 | 1,900,000 | 49,456,365 | - | - | 01 Nov 2021 01 Nov 2021 |
SAST (Reg31) | - | Release | |
Aurobindo Pharma | RPR SONS ADVISORS PRIVATE LIMITED. P.SUNEELA RANI Jointly holding | Promoter | Pledge | 24 Dec 2024 | 600,000 | 48,856,365 | - | - | 01 Nov 2021 01 Nov 2021 |
SAST (Reg31) | - | Release | |
Aurobindo Pharma | RPR Sons Advisors Private Limited, P.Suneela Rani (jointly holding) (Re-revised) | Promoter Group | Pledge | 21 Dec 2020 | 3,016,000 | 196,376,250 (33.51%) | 0.51% | 828.9 | 2,500,000,000 | 12 Oct 2020 12 Oct 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |
Aurobindo Pharma | RPR Sons Advisors Private Limited, P.Suneela Rani (jointly holding) (Revised) | Promoter Group | Revoke | 21 Dec 2020 | 3,016,000 | 196,376,250 (33.51%) | 0.51% | 828.9 | 2,500,000,000 | 12 Oct 2020 12 Oct 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |
Aurobindo Pharma | RPR Sons Advisors Private Limited, P.Suneela Rani (jointly holding) | Promoter Group | Pledge | 12 Oct 2020 | 3,016,000 | 196,376,250 (33.51%) | 0.51% | 828.9 | 2,500,000,000 | 12 Oct 2020 12 Oct 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |
Aurobindo Pharma | RPR Sons Advisors Private Limited, P.Suneela Rani (Jointly holding) | Promoter Group | Pledge | 10 Jul 2020 | 2,860,000 | 196,376,250 (33.51%) | 0.49% | 778.3 | 2,225,938,000 | 07 Jul 2020 07 Jul 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |